BeStock  
Stocks › Biotechnology › STTK

Shattuck Labs STTK

US equityMarket cap rank #3657Biotechnology
$5.66 −$0.21 (-3.50%)
Market closed · Oct 8, 6:40 am ET · Last extended-hours $5.66 0.00%
Open$5.76
Prev close$5.86
Day range$5.55 – $5.83
Volume1.11M
Market cap$567.55M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.2%last 3 reports
Closed higher1 of 333% of the time
Best reaction+4.4%
Worst reaction-6.8%

Stock move on the day after each report

-1.4%2021/Q2-6.8%2022/Q3+4.4%2022/Q4
QuarterReport dateTimingImplied moveActual moveVersus implied
2022/Q423 Feb 2023Pre Market–+4.37%–
2022/Q38 Nov 2022Pre Market±33.8%-6.75%Within range
2021/Q211 Aug 2021None–-1.38%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$16.16M-24.0% YoY
Net profit-$15.15M-21.6% YoY
Diluted EPS-$0.12+50.0% YoY
Free cash flow-$10.33M+1.0% YoY
Operating cash flow-$10.19M

Revenue, last 8 quarters

$3.0MSep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$1.0MSep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-16.7MSep '24$-18.7MDec '24$-13.7MMar '25$-12.5MJun '25$-10.1MSep '25$-12.6MDec '25$-14.8MMar '26$-15.2MJun '26

Profitability & balance sheet

Operating margin-5,578.6%
Net margin-5,256.8%
Return on equity-39.2%
Return on assets-36.9%
Return on invested capital-40.7%
Current ratio27.59
Liabilities / assets4.3%
Cash & investments$208.30M
Total debt$1.80M
Net cash (debt)$206.50M

Discussion

No comments yet — be the first to weigh in on STTK.

Leave a comment

Scroll to Top